Tetris Therapeutics is a platform-based biotechnology company
Axcynsis Therapeutics has raised $15.0M in total funding. The most recent round was Seed. The last funding was announced in May 2022.
Axcynsis Therapeutics's investors include Trinity Innovation Bioventure Singapore.
Axcynsis Therapeutics is headquartered in Singapore, Singapore.
Tetris Therapeutics is a platform-based biotechnology company
Axcynsis Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Axcynsis Therapeutics — Funding & Investors." VCBacked, May 4, 2022, https://www.vcbacked.co/company/axcynsis-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Axcynsis Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/axcynsis-therapeutics
{{cite web |title=Axcynsis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/axcynsis-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated